These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 28262335

  • 21. Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion.
    Bodle J, Verity EE, Ong C, Vandenberg K, Shaw R, Barr IG, Rockman S.
    Influenza Other Respir Viruses; 2013 Mar; 7(2):191-200. PubMed ID: 22583601
    [Abstract] [Full Text] [Related]

  • 22. An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines.
    Bodle J, Vandenberg K, Laurie K, Barr IG, Zhang Y, Rockman S.
    Front Immunol; 2023 Mar; 14():1147028. PubMed ID: 37033922
    [Abstract] [Full Text] [Related]

  • 23. Stability of neuraminidase in inactivated influenza vaccines.
    Sultana I, Yang K, Getie-Kebtie M, Couzens L, Markoff L, Alterman M, Eichelberger MC.
    Vaccine; 2014 Apr 17; 32(19):2225-30. PubMed ID: 24613525
    [Abstract] [Full Text] [Related]

  • 24. Application of recombinant hemagglutinin proteins as alternative antigen standards for pandemic influenza vaccines.
    Choi Y, Kwon SY, Oh HJ, Shim S, Chang S, Chung HJ, Kim DK, Park Y, Lee Y.
    Biotechnol Lett; 2017 Sep 17; 39(9):1375-1380. PubMed ID: 28612264
    [Abstract] [Full Text] [Related]

  • 25. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.
    Wang S, Taaffe J, Parker C, Solórzano A, Cao H, García-Sastre A, Lu S.
    J Virol; 2006 Dec 17; 80(23):11628-37. PubMed ID: 16987975
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay.
    van Kessel G, Geels MJ, de Weerd S, Buijs LJ, de Bruijni MA, Glansbeek HL, van den Bosch JF, Heldens JG, van den Heuvel ER.
    Vaccine; 2012 Jan 05; 30(2):201-9. PubMed ID: 22107849
    [Abstract] [Full Text] [Related]

  • 29. Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry.
    Williams TL, Pirkle JL, Barr JR.
    Vaccine; 2012 Mar 23; 30(14):2475-82. PubMed ID: 22197963
    [Abstract] [Full Text] [Related]

  • 30. Rapid determination of influenza vaccine potency by an SPR-based method using subtype or lineage-specific monoclonal antibodies.
    Narayan K, Paduraru C, Blake T, Arunachalam AB.
    Front Immunol; 2023 Mar 23; 14():1128683. PubMed ID: 37457687
    [Abstract] [Full Text] [Related]

  • 31. A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines.
    Byrne-Nash RT, Gillis JH, Miller DF, Bueter KM, Kuck LR, Rowlen KL.
    NPJ Vaccines; 2019 Mar 23; 4():3. PubMed ID: 30675394
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Avian glycan-specific IgM monoclonal antibodies for the detection and quantitation of type A and B haemagglutinins in egg-derived influenza vaccines.
    Legastelois I, Chevalier M, Bernard MC, de Montfort A, Fouque M, Pilloud A, Serraille C, Devard N, Engel O, Sodoyer R, Moste C.
    J Virol Methods; 2011 Dec 23; 178(1-2):129-36. PubMed ID: 21907241
    [Abstract] [Full Text] [Related]

  • 35. Influenza bivalent vaccine comprising recombinant H3 hemagglutinin (HA) and H1 HA containing replaced H3 hemagglutinin transmembrane domain exhibited improved heterosubtypic protection immunity in mice.
    Liu Q, Xue C, Zheng J, Liu K, Wang Y, Wei Y, Liu GD, Cao Y.
    Vaccine; 2015 Jul 31; 33(32):4035-40. PubMed ID: 26100927
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China.
    Li C, Shao M, Cui X, Song Y, Li J, Yuan L, Fang H, Liang Z, Cyr TD, Li F, Li X, Wang J.
    Biologicals; 2010 Mar 31; 38(2):284-9. PubMed ID: 20074976
    [Abstract] [Full Text] [Related]

  • 38. Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MSE.
    Creskey MC, Li C, Wang J, Girard M, Lorbetskie B, Gravel C, Farnsworth A, Li X, Smith DG, Cyr TD.
    Vaccine; 2012 Jul 06; 30(32):4762-70. PubMed ID: 22643214
    [Abstract] [Full Text] [Related]

  • 39. Development and characterization of standard reagents for cell-based prepandemic influenza vaccine products.
    Lai CC, Weng TC, Chen PL, Tseng YF, Lin CY, Chia MY, Sung WC, Lee MS, Hu AY.
    Hum Vaccin Immunother; 2020 Sep 01; 16(9):2245-2251. PubMed ID: 32118516
    [Abstract] [Full Text] [Related]

  • 40. Design and optimization of a multiplex anti-influenza peptide immunoassay.
    Drummond JE, Shaw EE, Antonello JM, Green T, Page GJ, Motley CO, Wilson KA, Finnefrock AC, Liang X, Casimiro DR.
    J Immunol Methods; 2008 May 20; 334(1-2):11-20. PubMed ID: 18329663
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.